FDA
The U.S. Food and Drug Administration (FDA) is the federal agency that decides whether drugs, biologics, and medical devices are safe and effective enough to be sold. AbilityForge cites it to show that denied treatments were already federally approved.
What It Is
The FDA is the federal gatekeeper for medical products. Before a drug, biologic, or device can be marketed in the United States, the FDA must review the scientific evidence and determine that it is safe and effective for its intended use. That review is rigorous, evidence-based, and legally binding — which is exactly why the phrase "FDA-approved" carries weight. It is not marketing language; it is a determination that the product cleared a federal evidentiary bar.
Why It Matters — Approved, Then Denied
The FDA matters to the denial cases because it draws a clean line the insurer cannot easily blur. When a treatment is FDA-approved, the federal government has already concluded that it works and is safe enough to sell. So when an insurer then refuses to pay for that same treatment — calling it "experimental," "investigational," or "not medically necessary" — there is a documented federal finding that says otherwise.
That gap — federally approved on one side, denied on the other — is one of the clearest tells in the record. The FDA gives the patient's claim an authority the payer's denial has to argue against.
How AbilityForge Uses It
Where a documented case turns on a treatment that was denied despite federal approval, the FDA is cited as the neutral standard the denial fails to meet. It is not the agency's role that is in question here — it is what happens after its approval is on the books.
The Same Playbook — Healthcare, Glyphosate, PFAS →Related Terms
Sources: U.S. FDA drug, biologic, and medical-device approval framework (Federal Food, Drug, and Cosmetic Act). Approval status is specific to a product and indication.